Novel CDK4/6 lnhibitor, WXJ-8 -Exerts Anti-effects Through Cell Cycle in Breast Cancer

• Main Authors: Jing Ji (Author), ZHEN ZHANG (Author), GUAN-CHUN LI (Author), LING-YI ZUO (Author), JIAO-JIAO ZHOU (Author), XIU-JUN WANG (Author), SHAO-JIE MA (Author), BIN LIU (Author), JIN-QING HAN (Author), XIAO HOU (Author)
• Format: Book
• Published: Polskie Towarzystwo Farmaceutyczne, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The novel Abemaciclib derivative WXJ-8 may be a promising anti-tumour drug; however, its mechanism of action and clinical value need to be further verified in research. Cell cycle regulating systems are critical in parthenogenesis and progression. Because of its involvement in regulating cell cycle...